Injective
INJ
Fundamental comparison between Injective and SPDR S&P 500 ETF (Ondo Tokenized ETF)
Not Financial Advice
This page is an informational analysis, not investment advice. The CryptoValue Score is an algorithmically generated rating from public data — it does not replace professional advice. Cryptocurrencies are highly volatile; total loss is possible. Read full risk disclaimer →
Injective
SPDR S&P 500 ETF (Ondo Tokenized ETF)
Detailed Comparison
| Metric | Injective | SPDR S&P 500 ETF (Ondo Tokenized ETF) |
|---|---|---|
| Price | $4.81 | $743.81 |
| Market Cap | $480.89M | $42.51M |
| 24h Volume | 61.9M | 1.1M |
| Rank | #— | #— |
| Circulating Supply | 100M | 57.1K |
| ATH | $52.62 | $770.10 |
Injective vs SPDR S&P 500 ETF (Ondo Tokenized ETF) — Analysis
Injective and SPDR S&P 500 ETF (Ondo Tokenized ETF) are two of the most prominent cryptocurrencies in the market. This comparison analyzes both coins based on their current price, market capitalization, trading volume, and — most importantly — their CryptoValue Value Score, which is calculated from 10 fundamental on-chain and market metrics.
Value Score Comparison
With a Value Score of 70.7, Injective is currently rated as "undervalued", while SPDR S&P 500 ETF (Ondo Tokenized ETF) scores 52.2 and is rated "fair value". This means our algorithm considers Injective the fundamentally stronger investment.
Market Cap & Risk
Injective has a 11x larger market capitalization than SPDR S&P 500 ETF (Ondo Tokenized ETF). A larger market cap typically means less volatility but also less growth potential. SPDR S&P 500 ETF (Ondo Tokenized ETF) may offer more upside but comes with higher risk.
Price Performance
Over the last 24 hours, Injective moved 4.90%, while SPDR S&P 500 ETF (Ondo Tokenized ETF) changed -1.00%. Looking at the 7-day window, Injective is at -7.90% and SPDR S&P 500 ETF (Ondo Tokenized ETF) at -1.10%.
Distance from All-Time High
Injective currently trades at 9% of its all-time high ($52.62), while SPDR S&P 500 ETF (Ondo Tokenized ETF) sits at 97% of its ATH ($770.10). Coins trading far below their ATH can represent either a buying opportunity or a warning sign — the Value Score helps distinguish between the two.
Conclusion
Based on our fundamental analysis, Injective (Score: 70.7) currently has a stronger investment case than SPDR S&P 500 ETF (Ondo Tokenized ETF) (Score: 52.2). However, the Value Score is a snapshot that changes daily. We recommend monitoring both coins regularly and conducting your own research before making any investment decisions.
